ZYBERNO
Stock Report
Updated Sep 1, 2026

Rocket One Inc. (RKTO)

Healthcare • NASDAQ

$0.69

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
18.0/100
POOR BUSINESS
Rocket One Inc. (RKTO) scores 18/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-199.2%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-3,080.8%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Rocket One Inc. (RKTO) stock report — Zyberno Score 18/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.69
Market Cap:$14.13M

Valuation Multiples (2)

P/B Ratio:1.72x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$6.25M

Price Action & Momentum (1)

% of 52-Week High:28.1%
B. Profitability Assessment

Return Metrics (5)

ROA:-166.4%
Reinvestment Rate:0.0%
Fundamental Growth Rate (g):0.0%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$107.34
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-34.5%
Latest Earnings Filed:2026-08-14
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:6.20x
Quick Ratio:6.20x
Cash Ratio:5.70x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x
Debt-to-Equity Ratio:0.00x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:7,197,187.00
Cash And Cash Equivalents:7,891,911.00
Long Term Debt:$5.68K
Net Debt:-$7.88M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$13.17M

Bottom Line Performance (3)

-$13.32M
Income Before Tax:-$3.83M
Ebitda Ttm:-13,168,932.00

Operating Expenses (5)

Operating Expenses:13,168,932.00
R And D Expense:6,422,421.00
Sga Expense:6,746,511.00
Income Tax Expense:$0.00
Interest Expense:0.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$9.58M
Current Assets:$8.58M
Ppe Net:0.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:1,383,733.00
Current Liabilities:1,383,733.00
Long Term Debt:$5.68K
Short Term Debt:$5.68K

Equity & Capital (3)

Equity:$8.20M
Retained Earnings:-$79.41M
Common Stock:50,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:1,003,947.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:677,079.00
C. Cash Flow Analysis

Operating Activities (2)

-$10.07M$0.00

Investment Activities (1)

Investing Cash Flow:$147.20K

Financing Activities (3)

Financing Cash Flow:$701.48K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:701,484.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.82
-$0.82
Earnings Per Share Ttm:-$0.65

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$0.48

Book Value & Capital (2)

Book Value Per Share:$0.40
Cash Per Share:0.38

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:0.0%
Fundamental Growth Rate (g):0.0%
B. Log-Linear Regression Growth Analysis

Other Growth Rates (1)

Book Value Growth Rate (Linear):-9.3%
C. Company Profile & Context

Corporate Information (6)

Symbol:RKTO
Company Name:Rocket One Inc.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:20.55M
Shares Outstanding Basic:20.55M
Shares Outstanding Diluted:20.55M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 08:49:03 UTC
Data Timestamp:2026-08-20T22:13:21.243105
Scroll to Top